Diseases, Conditions, Syndromes

Better Asthma and COPD Drugs with Fewer Side Effects Are Within Reach

Bronchodilators, the most common type of asthma-fighting drug, inhibits contractions of airway smooth muscle that are induced by stimulating receptors on the muscle's surface. New research highlights a novel mechanism for ...

Diseases, Conditions, Syndromes

Spirometry may aid diagnosis of asthma versus COPD in primary care

The ability of physicians to differentiate between asthma and chronic obstructive pulmonary disease (COPD) in the primary care setting may be improved with the addition of spirometry testing, according to a study published ...

Diseases, Conditions, Syndromes

Bronchitis in childhood linked to adult lung problems

Bronchitis in early childhood has been found to increase the risk of lung diseases in middle age according to research from the Allergy and Lung Health Unit at the University of Melbourne.

Medications

First generic of symbicort receives FDA approval

The U.S. Food and Drug Administration approved the first generic of Symbicort (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol to treat asthma in patients 6 years and older and for maintenance treatment in ...

Diseases, Conditions, Syndromes

Improving diagnosis of asthma-COPD overlap

A University of Texas at Arlington faculty member and nurse practitioner (NP) said she hopes to bring more attention to an underrecognized condition.

Immunology

Asthma, COPD tied to worse COVID-19 outcomes

(HealthDay)—Patients with active asthma or chronic obstructive pulmonary disease (COPD) are at increased risk for severe COVID-19 outcomes, according to a study published online Aug. 10 in the Journal of Allergy and Clinical ...

page 3 from 9